Stories Tagged as
Pfizer
COVID-19 economy wanes along with pandemic's urgency
Oct 17, 2023
Makers of vaccines, tests and even protective gear are struggling to adjust to slackening demand.
Will FDA approval bring a wave of vaccine mandates?
by
Matt Levin
Aug 23, 2021
Mandates will be detrimental to employers in a tight job market.
The upside of the vaccine rollout for the companies making shots
by
Andy Uhler
May 3, 2021
The resulting goodwill may prove useful to Pfizer and Moderna.
Simmering tensions over EU vaccine distribution threaten to boil over
Jan 27, 2021
The 27-nation bloc is battling with manufacturers over its spot in the priority list for receiving COVID vaccines.
The cost of "vaccine nationalism": $9 trillion
Jan 26, 2021
With shortfalls in vaccine supplies, countries across the world are concerned about getting their fair share of doses.
Could relaxing patents help poorer countries get vaccines faster?
Dec 15, 2020
India, South Africa, and Kenya want to try. The U.S., EU and U.K. aren't interested.
Dry ice makers pressed to meet demand for vaccine distribution
by
Erika Beras
Dec 11, 2020
Supercold storage is essential. But Is there enough dry ice to go around as the coronavirus vaccine is shipped around the country?
For public good, not for profit.
Vaccine delivery across the country faces complex supply chain challenges
by
Scott Tong
Dec 10, 2020
Within 24 hours of emergency authorization from the Food and Drug Administration, the vaccine maker Pfizer plans to move the product to patients nationwide.
U.K. is first to green light Pfizer-BioNTech COVID-19 vaccine
Dec 2, 2020
Fifty U.K. hospitals are on standby to administer vaccine shots, which will be available by next week.
AstraZeneca vaccine is third to show promising data in unprecedented hurry-up race
by
Scott Tong
Nov 23, 2020
The COVID-19 vaccine is being produced so quickly due to a combination of factors involving the research community, government, industry and the public.